Trial to evaluate safety and efficacy of MVA-BN vaccine
Category: News
New initiatives to tackle AI-related challenges in life sciences
Phase 1 and 2 studies show promising results for anito-cel therapy
New therapy targets specific genetic alterations, promises extended survival
Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020
The new Dementia Trials Accelerator is set to receive £20m of government funding
Approximately 8.2 million people were diagnosed with the infectious disease in 2023
danicopan shown to improve haemoglobin levels and reduce anaemia
New treatment option for patients with newly diagnosed multiple myeloma
CAL101 shows promising results and is set to enter phase 2 development